想

2586DIAMONDETAL.34.Ochsenbein,A.F.,T.Fehr,C.Lutz,M.Suter,F.Brombacher,H.Hengart-ner,andR.M.Zinkernagel.1999.Controlofearlyviralandbacterialdis-tributionanddiseasebynaturalantibodies.Science286:2156–2159.

35.Ochsenbein,A.F.,D.D.Pinschewer,B.Odermatt,M.C.Carroll,H.Hen-gartner,andR.M.Zinkernagel.1999.ProtectiveTcell-independentantivi-ralantibodyresponsesaredependentoncomplement.J.Exp.Med.190:1165–1174.

36.Ochsenbein,A.F.,andR.M.Zinkernagel.2000.Naturalantibodiesand

complementlinkinnateandacquiredimmunity.Immunol.Today21:624–630.

37.Ramakrishna,C.,S.A.Stohlman,R.D.Atkinson,M.J.Shlomchik,and

C.C.Bergmann.2002.Mechanismsofcentralnervoussystemviralpersis-tence:thecriticalroleofantibodyandBcells.J.Immunol.168:1204–1211.38.Roehrig,J.T.,L.A.Staudinger,A.R.Hunt,J.H.Mathews,andC.D.Blair.

2001.Antibodyprophylaxisandtherapyfor aviviralencephalitisinfections.Ann.N.Y.Acad.Sci.951:286–297.

39.Saurwein-Teissl,M.,T.L.Lung,F.Marx,C.Gschosser,E.Asch,I.Blasko,

W.Parson,G.Bock,D.Schonitzer,E.Trannoy,ckofantibodyproductionfollowingimmunizationinoldage:associationwithCD8 CD28 TcellclonalexpansionsandanimbalanceintheproductionofTh1andTh2cytokines.J.Immunol.168:5893–5899.40.Schlesinger,J.J.,M.W.Brandriss,andE.E.Walsh.1985.Protection

against17Dyellowfeverencephalitisinmicebypassivetransferofmono-clonalantibodiestothenonstructuralglycoproteingp48andbyactiveim-munizationwithgp48.J.Immunol.135:2805–2809.

41.Schlesinger,J.J.,M.Foltzer,andS.Chapman.1993.TheFcportionof

antibodytoyellowfevervirusNS1isadeterminantofprotectionagainstYFencephalitisinmice.Virology192:132–141.

42.Scott,D.W.,andR.K.Gershon.1970.Determinationoftotalandmere-captoethanol-resistantantibodyinthesameserumsample.Clin.Exp.Im-munol.6:313–316.

J.VIROL.

43.Seiler,P.,U.Kalinke,T.Rulicke,E.M.Bucher,C.Bose,R.M.Zinkernagel,

andH.Hengartner.1998.Enhancedvirusclearancebyearlyinduciblelym-phocyticchoriomeningitisvirus-neutralizingantibodiesinimmunoglobulin-transgenicmice.J.Virol.72:2253–2258.

44.Stanley,J.,S.J.Cooper,andD.E.Grif n.1986.Monoclonalantibodycure

andprophylaxisoflethalSindbisvirusencephalitisinmice.J.Virol.58:107–115.

45.Tardei,G.,S.Ruta,V.Chitu,C.Rossi,T.F.Tsai,andC.Cernescu.2000.

EvaluationofimmunoglobulinM(IgM)andIgGenzymeimmunoassaysinserologicdiagnosisofWestNilevirusinfection.J.Clin.Microbiol.38:2232–2239.

46.Tsai,T.F.,F.Popovici,C.Cernescu,G.L.Campbell,andN.I.Nedelcu.

ncet352:767–771.

47.Tyler,K.L.,M.A.Mann,B.N.Fields,andH.W.VirginIV.1993.Protective

anti-reovirusmonoclonalantibodiesandtheireffectsonviralpathogenesis.J.Virol.67:3446–3453.

48.Tyor,W.R.,S.Wesselingh,B.Levine,andD.E.Grif n.1992.Longterm

intraparenchymalIgsecretionafteracuteviralencephalitisinmice.J.Im-munol.149:4016–4020.

49.Wang,T.,J.F.Anderson,L.A.Magnarelli,S.J.Wong,R.A.Koski,andE.

Fikrig.2001.ImmunizationofmiceagainstWestNileviruswithrecombinantenvelopeprotein.J.Immunol.167:5273–5277.

50.Weiner,L.P.,G.A.Cole,andN.Nathanson.1970.Experimentalencepha-litisfollowingperipheralinoculationofWestNilevirusinmiceofdifferentages.J.Hyg.(London)68:435–446.

51.Weksler,M.E.,andP.Szabo.2000.TheeffectofageontheB-cellreper-toire.J.Clin.Immunol.20:240–249.

52.Zinkernagel,R.M.,Marre,A.Ciurea,L.Hunziker,A.F.Ochsenbein,

K.D.McCoy,T.Fehr,M.F.Bachmann,U.Kalinke,andH.Hengartner.2001.Neutralizingantiviralantibodyresponses.Adv.Immunol.79:1–53.

Downloaded from at Sun Yat-Sen University on March 1, 2010